Titre : Syndrome de Kearns-Sayre

Syndrome de Kearns-Sayre : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome de Kearns-Sayre : Questions médicales les plus fréquentes", "headline": "Syndrome de Kearns-Sayre : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome de Kearns-Sayre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-22", "dateModified": "2025-02-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome de Kearns-Sayre" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ophtalmoplégie externe progressive", "url": "https://questionsmedicales.fr/mesh/D017246", "about": { "@type": "MedicalCondition", "name": "Ophtalmoplégie externe progressive", "code": { "@type": "MedicalCode", "code": "D017246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.511" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome de Kearns-Sayre", "alternateName": "Kearns-Sayre Syndrome", "code": { "@type": "MedicalCode", "code": "D007625", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Diego Martinelli", "url": "https://questionsmedicales.fr/author/Diego%20Martinelli", "affiliation": { "@type": "Organization", "name": "Division of Metabolism, IRCCS Bambino Gesù Children's Hospital, 00165, Rome, Italy." } }, { "@type": "Person", "name": "Glen Lester Sequiera", "url": "https://questionsmedicales.fr/author/Glen%20Lester%20Sequiera", "affiliation": { "@type": "Organization", "name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada." } }, { "@type": "Person", "name": "Abhay Srivastava", "url": "https://questionsmedicales.fr/author/Abhay%20Srivastava", "affiliation": { "@type": "Organization", "name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada." } }, { "@type": "Person", "name": "Keshav Narayan Alagarsamy", "url": "https://questionsmedicales.fr/author/Keshav%20Narayan%20Alagarsamy", "affiliation": { "@type": "Organization", "name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada." } }, { "@type": "Person", "name": "Cheryl Rockman-Greenberg", "url": "https://questionsmedicales.fr/author/Cheryl%20Rockman-Greenberg", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics and Child Health, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 3P4, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Patient satisfaction - results of cluster analysis of finnish patients.", "datePublished": "2023-06-13", "url": "https://questionsmedicales.fr/article/37312180", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09625-y" } }, { "@type": "ScholarlyArticle", "name": "RNAprofiling 2.0: Enhanced Cluster Analysis of Structural Ensembles.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36933824", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jmb.2023.168047" } }, { "@type": "ScholarlyArticle", "name": "Analysis of the Intelligent Tourism Route Planning Scheme Based on the Cluster Analysis Algorithm.", "datePublished": "2022-06-28", "url": "https://questionsmedicales.fr/article/35800698", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/3310676" } }, { "@type": "ScholarlyArticle", "name": "Analysis of Graphic Perception Education for Young Children Based on Fuzzy Clustering Analysis.", "datePublished": "2022-06-21", "url": "https://questionsmedicales.fr/article/35774433", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/8046713" } }, { "@type": "ScholarlyArticle", "name": "Comparative Analysis of the Performance of Complex Texture Clustering Driven by Computational Intelligence Methods Using Multiple Clustering Models.", "datePublished": "2022-09-29", "url": "https://questionsmedicales.fr/article/36210982", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/8449491" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Paralysie", "item": "https://questionsmedicales.fr/mesh/D010243" }, { "@type": "ListItem", "position": 6, "name": "Ophtalmoplégie", "item": "https://questionsmedicales.fr/mesh/D009886" }, { "@type": "ListItem", "position": 7, "name": "Ophtalmoplégie externe progressive", "item": "https://questionsmedicales.fr/mesh/D017246" }, { "@type": "ListItem", "position": 8, "name": "Syndrome de Kearns-Sayre", "item": "https://questionsmedicales.fr/mesh/D007625" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome de Kearns-Sayre - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome de Kearns-Sayre", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome de Kearns-Sayre", "description": "Comment diagnostique-t-on le syndrome de Kearns-Sayre ?\nQuels tests génétiques sont utilisés ?\nQuels signes cliniques sont observés ?\nL'électrocardiogramme est-il utile ?\nLes biopsies musculaires sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome de Kearns-Sayre", "description": "Quels sont les symptômes principaux ?\nLa fatigue est-elle un symptôme fréquent ?\nY a-t-il des problèmes de vision ?\nLes troubles de l'équilibre sont-ils possibles ?\nLes patients peuvent-ils avoir des douleurs musculaires ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome de Kearns-Sayre", "description": "Peut-on prévenir le syndrome de Kearns-Sayre ?\nLes tests génétiques peuvent-ils aider ?\nLes conseils génétiques sont-ils utiles ?\nLes femmes enceintes doivent-elles être testées ?\nY a-t-il des recommandations pour les familles ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome de Kearns-Sayre", "description": "Quel est le traitement principal du syndrome ?\nLes suppléments de coenzyme Q10 sont-ils utiles ?\nDes médicaments sont-ils prescrits pour la cardiomyopathie ?\nLa physiothérapie est-elle recommandée ?\nY a-t-il des traitements pour les troubles de la vision ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome de Kearns-Sayre", "description": "Quelles sont les complications possibles ?\nLe syndrome peut-il affecter la qualité de vie ?\nY a-t-il un risque accru de diabète ?\nLes troubles de la mémoire sont-ils fréquents ?\nLes patients sont-ils à risque d'infections ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome de Kearns-Sayre", "description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nL'âge d'apparition est-il variable ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLes mutations génétiques sont-elles héréditaires ?", "url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le syndrome de Kearns-Sayre ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, l'IRM et des tests génétiques." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests pour détecter des mutations dans l'ADN mitochondrial sont effectués." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ophtalmoplégie, troubles cardiaques et anomalies neurologiques sont typiques." } }, { "@type": "Question", "name": "L'électrocardiogramme est-il utile ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut montrer des anomalies cardiaques associées au syndrome." } }, { "@type": "Question", "name": "Les biopsies musculaires sont-elles nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être réalisées pour détecter des anomalies mitochondriales." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ophtalmoplégie, cardiomyopathie, surdité et troubles neurologiques." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme fréquent ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue chronique est courante chez les patients atteints." } }, { "@type": "Question", "name": "Y a-t-il des problèmes de vision ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles visuels comme la ptose et la rétinopathie peuvent survenir." } }, { "@type": "Question", "name": "Les troubles de l'équilibre sont-ils possibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes d'équilibre et de coordination peuvent se manifester." } }, { "@type": "Question", "name": "Les patients peuvent-ils avoir des douleurs musculaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires et des crampes sont souvent rapportées." } }, { "@type": "Question", "name": "Peut-on prévenir le syndrome de Kearns-Sayre ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention, car c'est une maladie génétique." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier les porteurs et informer les familles." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident les familles à comprendre les risques de transmission." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être testées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Si des antécédents familiaux existent, un test peut être recommandé." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les familles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conseils sur la gestion des symptômes et le soutien psychologique." } }, { "@type": "Question", "name": "Quel est le traitement principal du syndrome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement curatif, mais des soins symptomatiques sont offerts." } }, { "@type": "Question", "name": "Les suppléments de coenzyme Q10 sont-ils utiles ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à améliorer la fonction mitochondriale." } }, { "@type": "Question", "name": "Des médicaments sont-ils prescrits pour la cardiomyopathie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme les bêtabloquants peuvent être utilisés." } }, { "@type": "Question", "name": "La physiothérapie est-elle recommandée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à améliorer la force et la mobilité." } }, { "@type": "Question", "name": "Y a-t-il des traitements pour les troubles de la vision ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des aides visuelles et des interventions chirurgicales peuvent être envisagées." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance cardiaque et des troubles neurologiques." } }, { "@type": "Question", "name": "Le syndrome peut-il affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent gravement impacter la qualité de vie des patients." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent développer un diabète de type 2." } }, { "@type": "Question", "name": "Les troubles de la mémoire sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs et de la mémoire peuvent survenir." } }, { "@type": "Question", "name": "Les patients sont-ils à risque d'infections ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une immunité affaiblie peut augmenter le risque d'infections." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de maladies mitochondriales sont un facteur de risque." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Non, le syndrome affecte les hommes et les femmes de manière égale." } }, { "@type": "Question", "name": "L'âge d'apparition est-il variable ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent apparaître entre l'enfance et l'âge adulte." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'y a pas de preuves solides sur l'influence environnementale." } }, { "@type": "Question", "name": "Les mutations génétiques sont-elles héréditaires ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les mutations peuvent être transmises par la mère à l'enfant." } } ] } ] }

Sources (10000 au total)

Patient satisfaction - results of cluster analysis of finnish patients.

Healthcare providers must understand patients' expectations and perceptions of the care they receive to provide high-quality care. The purpose of this study is to identify and analyse different cluste... A cross-sectional design was applied. The data were collected in 2017 from three Finnish acute care hospitals with the Revised Humane Caring Scale (RHCS) as a paper questionnaire, including six backgr... A total of 1810 patients participated in the study. Patient satisfaction was categorised into four groups: dissatisfied (n = 58), moderately dissatisfied (n = 249), moderately satisfied (n = 608), and... The results mostly demonstrated high levels of patient satisfaction; however, the perceptions of minority populations of dissatisfied patients should be assessed to identify shortcomings in the care p...

Cluster analysis of cancer knowledge, attitudes and behaviors in the Moroccan population.

Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic consequences and the heavy financial burden incurred by cancer patients.... We conducted a cross-sectional survey of adult patients at Mohamed Sekkat and Sidi Othmane Hospitals in Casablanca, Morocco. Data collection was conducted by two trained interviewers who administered ... The cluster-based analysis showed that participants in cluster 1 had the highest mean attitude score (13.9 ± 2.15) and percentage of individuals with a high level of knowledge (50.8%) whereas the lowe... The findings showed that female individuals living in rural settings, belonging to an older age group, who were least likely to use health professionals as an information source had the lowest levels ...

Predicting seizure clustering in the epilepsy monitoring unit: A multivariable analysis.

Seizure clustering, is the most frequently reported adverse event in epilepsy monitoring unit (EMU) safety studies which, can also potentiate other adverse events, such as falls, status epilepticus, a... A retrospective review of patients admitted to the EMU over a two-year period was completed. Data collected included patient demographics, types of epilepsy, seizure frequency, anti-seizure medication... Two hundred seven patients were included in our study; of these, ninety patients experienced two or more seizures in a 24-hour period (24SC), and 68 patients experienced two or more seizures in a 4-ho... Our data showed that long-acting ASMs can be protective against seizure clustering. Furthermore, patients with temporal lobe epilepsy, and those on increased numbers of ASMs, were more likely to exper...

Identifying phenotypes of obstructive sleep apnea using cluster analysis.

Over the last decade, advances in understanding the pathophysiology, clinical presentation, systemic consequences and treatment responses in obstructive sleep apnea (OSA) have made individualised OSA ... Patients diagnosed with OSA on level 1 polysomnography (PSG) were included. Clinical and co-morbidity profile, anthropometry and sleepiness scores were compiled. On PSG, apnea-hypopnea index, position... One hundred patients (66 males) with a mean age of 49.5 ± 13.3 years were included. Snoring was reported by 94% subjects, and 50% were excessively sleepy. Two-thirds of subjects had co-morbidities, th... This study revealed three OSA clusters with distinct demographic, anthropometric and PSG features. Further research with bigger sample size and additional parameters may pave the way for characterisin...

Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.

Previous studies suggested that distinct phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) could be determined by the presence or absence of ... This study used standardized data of 15 European centers for patients with EGPA fulfilling widely accepted classification criteria. We used multiple correspondence analysis, hierarchical cluster analy... The analyses included 489 patients diagnosed between 1984 and 2015. ANCA were detected in 37.2% of patients, mostly perinuclear ANCA (85.4%) and/or antimyeloperoxidase (87%). Compared with ANCA-negati... Although reinforcing the known association of ANCA status with clinical manifestations, cluster analysis does not support a complete separation of EGPA in ANCA-positive and -negative subsets. Collecti...

Erosive arthritis in systemic lupus erythematosus: application of cluster analysis.

In the present study, we applied cluster analysis (CA) in SLE patients with joint involvement to identify which disease subset most commonly develops erosive damage.... We collected clinical and laboratory data of SLE patients with a clinical history of joint involvement (arthritis/arthralgia). Ultrasonographic assessment was performed at level of MCPs and PIPs joint... CA included 112 SLE patients (M/F 6/106; median age 45 years, IQR 17; median disease duration 96 months, IQR 165). Arthritis was observed in 82 patients (73.2%) and inflammatory arthralgia in 30 (26.8... The application of CA made it possible to better characterise SLE phenotype including erosive arthritis. In particular, feature-driven CA leads to the identification of a more aggressive disease, due ...